Volume : 6, Issue : 8, AUG 2020

SOCIO ECONOMIC ANALYSIS OF HEALTH CARE SERVICES OF WORKING WOMEN IN CUDDALORE DISTRICT.

DR. S.THANIKASALAM

Abstract

It is fact and true’s that economical and social status and condition of the people in global contexts would not be same but it would be varied according their social and economical status from their ancestor’s periods onwards. Status is classified into several and plethora categories such as income, job, property status, education status, cultural developments, political status and other bank saving status. Based on these categories people’s status have been varied since beginning of the world system, in which every one of us want to get status in those fields by competing with others both directly and indirectly. Due to this competition regular conflicts and sporadic conflicts are arising between people to people and community to community with an intention to increase their profile before others and equal to others in the society. From these aspects this study is designed to analysis social and economical factors and status of the health care women in cuddalore district, in this way this study is aimed at exploring of their nature of job, income and other factors relating to their occupation which propels their social and economic status would be analyzed. Definitely ,people would be varied on account of known factors of the above said factors though they work lot will not able to progress in their life due to weak basic property status and parents situations.

Keywords

SOCIAL STATUS, HOSPITAL SYSTEM, ADMINISTRATIVE MECHANISM, WORKER’S NEEDS AND EXPECTATIONS.

Article : Download PDF

Cite This Article

Article No : 10

Number of Downloads : 701

References

  1. Christian MS. Human Capital Accounting in the United States: 1994 to 2006. University of Wisconsin, Center for Education Research; 2010. [accessed September 2010]. Available: https://www.bea.gov/about/pdf/Christian_humancapital_20091101.pdf.
  2. Clabaugh G, Ward MM. Cost-of-illness studies in the United States: A systematic review of methodologies used for direct cost. Value in Health. 2008;11:13–21. [PubMed]
  3. Cohen JW, Krauss NA. Spending and service use among people with the 15 most costly medical conditions, 1997. Health Affairs. 2003;22(2):129–138. [PubMed]
  4. Colecchia A, Schreyer P. The contribution of information and communication technologies to economic growth in nine OECD countries. OECD Economic Studies. 2002;34:154–171.
  5. Cooper BS, Rice DP. The economic cost of illness revisited. Social Security Bulletin. 1976;39:21–36. [PubMed]
  6. Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, Van Lente F, Levey AS. Prevalence of chronic kidney disease in the United States. Journal of the American Medical Association. 2007;298:2038–2047. [PubMed]
  7. Cutler DM. Your Money or Your Life: Strong Medicine for America’s Health Care System. Cary NC: Oxford University Press; 2004.
  8. Cutler DM, Berndt ER, editors. Medical Care Output and Productivity. Cambridge, MA: National Bureau of Economic Research; 2001.
  9. Cutler DM, McClellan M. Is technological change in medicine worth it? Health Affairs. 2001;20(September/October):11–29. [PubMed]
  10. Cutler DM, McClellan M, Newhouse JP, Remler D. Are medical prices declining? Evidence for heart attack treatments. Quarterly Journal of Economics. 1998;113(4,vember):991–1024.
  11. Cutler DM, McClellan M, Newhouse JP, Remler D. Pricing heart attack treatments. Medical Care Output and Productivity. Cutler DM, Berndt ER, editors. Chicago, IL: University of Chicago Press; 2001. pp. 305–362. National Bureau of Economic Research Studies in Income and Wealth Series, 62.
  12. Cutler DM, Rosen AB, Vijan S. The value of medical spending in the United States, 1960–2000. New England Journal of Medicine. 2006;355(August):920–927. [PubMed]
  13. D’Agostino RB, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, Kennel WG. General cardiovascular risk profile for use in primary care. The Framingham heart study. Circulation. 2008. [accessed May 2010]. pp. 743–753. Available: http://circ.ahajournals.org/cgi/reprint/117/6/743. [PubMed]
  14. Danzon PM, Furukawa MF. Prices and availability of biopharmaceuticals: An international comparison. Health Affairs. 2006;25(5):1353–1362. [PubMed]
  15. Danzon PM, Furukawa MF. International prices and availability of pharmaceuticals in 2005. Health Affairs. 2008;27(1):221–233. [PubMed]
  16. Danzon PM, Wang YR, Wang L. The impact of price regulation on the launch delay of new drugs. Health Economics. 2005. [accessed May 2010]. pp. 269–292. Available: http://hc.wharton.upenn.edu/danzon/PDF%20Files/Impact%20of%20Price%20Regulation%20-%20Health%20Economics%202005.pdf. [PubMed]
  17. Davis K. Paying for care episodes and care coordination. New England Journal of Medicine. 2007;356:1166–1168. [PubMed]
  18. Dawson D, Gravelle H, O’Mahony M, Street A, Weale M, Castelli A, Jacobs R, Kind P, Loveridge P, Martin S, Stevens P, Stokes L. Developing New Approaches to Measuring NHS Outputs and Productivity, Final Report. York, England: Centre for Health Economics; 2005.
  19. DeVol R, Bedroussian A. An Unhealthy America: The Economic burden of Chronic Disease: Charting a New Course to Save Lives and Increase Productivity and Economic Growth. Washington, DC: Milken Institute; 2007. [accessed May 2010]. Available: http://www.milkeninstitute.org/publications/publications.taf?function=detail&ID=38801018&cat=resrep.
  20. Diewert E, Mizobuchi H. An Economic Approach to the Measurement of Productivity Growth Using Differences Instead of Ratios. Discussion Paper 09-03, Department of Economics, University of British Columbia. 2009. [accessed May 2010]. Available: http://faculty.arts.ubc.ca/ediewert/dp0903.pdf.
  21. Douglas J. Measurement of Public Sector Output and Productivity. New Zealand Treasury Policy Perspectives Paper No. 06/09. 2006. [accessed May 2010]. Available: http://www.treasury.govt.nz/publications/research-policy/ppp/2006/06-09/
  22. Druss BG, Marcus SC, Olfson M, Tanielian T, Elinson L, Pincus HA. Comparing the national economic burden of five chronic conditions. Health Affairs. 2001;20(6):233–242. [PubMed]
  23. Eggleston K, Shah ND, Smith SA, Wagie AE, Williams AR, Grossman JH, Berndt ER, Long KH, Bannerjee R, Newhouse JP. The net value of health care for patients with type 2 diabetes, 1997–2005. Annals of Internal Medicine. 2009;151(6):386–393. [PubMed]
  24. Elixhauser A, Steiner C, Palmer L. Clinical Classifications Software (CCS), 2007. Washington, DC: Agency for Healthcare Research and Quality; 2007. [accessed May 2010]. Available: http://www.hcup-us.ahrq.gov.
  25. Ellis RP, Pope GC, Iezzoni LI, Ayanian JZ, Bates DW, Ash A. Diagnosis-based risk adjustment for Medicare capitation payments. Health Care Financing Review. 1996;17(3):101–128. [PMC free article] [PubMed]
  26. Employers Health Coalition. The Hidden Competitive Edge: Employee Health and Productivity. Newton, MA: Managed Care Communications; 2000.
  27. Englander F, Hodgson TJ, Terragrossa RA. Economic dimensions of slip and fall injuries. Journal of Forensic Science. 1996;41:733–746. [PubMed]
  28. Erickson P. Evaluation of a population-based measure of quality of life: The health and activity limitation index (HALex). Quality of Life Research. 1998;7(2):101–114. [PubMed]
  29. Erickson P, Kendall EA, Anderson JP, Kaplan RM. Using composite health status measures to assess the nation’s health. Medical Care. 1989;27(3 Suppl):S66–S76. [PubMed]
  30. Erickson P, Wilson R, Shannon I. Years of healthy life. Healthy People 2000 Statistical Notes. 1995;7:1–15. [PubMed]
  31. Etches V, Frank J, Di Ruggiero E, Manuel D. Measuring population health: A review of indicators. Annual Review of Public Health. 2006;27:29–55. [PubMed]
  32. Ettaro L, Songer TJ, Zhang P, Engelgau MM. Cost-of-illness studies in diabetes. PharmacoEconomics. 2004;22(3):149–164. [PubMed]
  33. Eurostat. Handbook on Price and Volume Measures in National Accounts. Luxembourg, Germany: European Communities; 2001.
  34. Evans RG, Stoddart GL. Producing health, consuming health care. Social Science and Medicine. 1990;31:1347–1363. [PubMed]
  35. Feenstra RC, Shapiro MD. High-frequency substitution and the measurement of price indexes, Scanner Data and Price Indexes. Cambridge, MA: National Bureau of Economic Research; 2003. pp. 123–150.
  36. Feenstra RC, Diewert EW.U.S. Office of Prices and Living Conditions. Imputation and Price Indexes: Theory and Evidence from the International Price Program. Washington, DC: Bureau of Labor Statistics; 2001.
  37. Feeny D, Torrance G, Furlong W. Health Utilities Index: Quality of Life and Pharmacoeconomics in Clinical Trials. Philadelphia, PA: Lippincott-Raven Press; 1996.
  38. Feeny D, Furlong W, Torrance GW, Goldsmith CH, Zhu Z, DePauw S, Denton M, Boyle M. Multiattribute and single-attribute utility functions for the health utilities index mark 3 system. Medical Care. 2002;40(2):113–128. [PubMed]
  39. Fisher ES, Wennberg DE, Stukel TA, Gottlieb DJ, Lucas FL, Pinder EL. The implications of regional variations in Medicare spending: Health outcomes and satisfaction with care. Annals of Internal Medicine. 2003;138(February 18):288–298. [PubMed]
  40. Fisher FM. Aggregation: Aggregate Production Function and Related Topics. Cambridge, MA: MIT Press; 1993.
  41. Fisher F, Shell K. The Economic Theory of Price Indices: Two Essays on the Effects of Taste, Quality, and Technological Change. New York: Academic Press; 1972.
  42. Fixler DJ. The Treatment and Price of Health Insurance in the CPI. Washington, DC: Bureau of Labor Statistics; 1996.
  43. Fixler D, Ginsburg M. Health care output and prices in the producer price index. Medical Care Output and Productivity. Cutler DM, Berndt ER, editors. Cambridge, MA: National Bureau of Economic Research; 2001. pp. 221–227.